EUVIMEDEUVIMED entdecken
Crossref

Artificial intelligence algorithm accurately assesses oestrogen receptor immunohistochemistry in metastatic breast cancer cytology specimens: A pilot study

Brenna C Li, Scott Hammond, Anil V Parwani, Rulong Shen iD

Cytopathology · 2024-07 · 35 (4) · 464-472

DOI: 10.1111/cyt.13373 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytopathology, online erschienen am 22.03.2024. Verfasst von Brenna C Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dublin Jerome High School, Dublin, Ohio, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Receptors, Estrogen, Immunohistochemistry, Algorithms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The Visiopharm artificial intelligence (AI) algorithm for oestrogen receptor (ER) immunohistochemistry (IHC) in whole slide images (WSIs) has been successfully validated in surgical pathology. This study aimed to assess its efficacy in cytology specimens.

Methods

The study cohort comprised 105 consecutive cytology specimens with metastatic breast carcinoma. ER IHC WSIs were seamlessly integrated into the Visiopharm platform from the Image Management System (IMS) during our routine digital workflow, and an AI algorithm was employed for analysis. ER AI scores were compared with pathologists' manual consensus scores. Optimization steps were implemented and evaluated to reduce discordance.

Results

The overall concordance between pathologists' scores and AI scores was excellent (99/105, 94.3%). Six cases exhibited discordant results, including two false‐negative (FN) cases due to abundant histiocytes incorrectly counted as negatively stained tumour cells by AI, two FN cases owing to weak staining, and two false‐positive (FP) cases where pigmented macrophages were erroneously counted as positively stained tumour cells by AI. The Pearson correlation coefficient of ER‐positive percentages between pathologists' and AI scores was 0.8483. Optimization steps, such as lowering the cut‐off threshold and additional training using higher input magnification, significantly improved accuracy.

Conclusions

The automated ER AI algorithm demonstrated excellent concordance with pathologists' assessments and accurately differentiated ER‐positive from ER‐negative metastatic breast carcinoma cytology cases. However, precision in identifying tumour cells in cytology specimens requires further enhancement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsReceptors, EstrogenImmunohistochemistryAlgorithmsArtificial IntelligenceCytodiagnosisHumansFemalePilot ProjectsNeoplasm MetastasisMiddle AgedAdultAged

Stichwörter der Autor:innen

artificial intelligencebreast cancercytologydigital image analysisimmunohistochemistryoestrogen receptor

Substanzen

Receptors, Estrogen

Autor:innen und Institutionen

  • Dublin Jerome High School, Dublin, Ohio, USA.
  • Department of Pathology, Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA.

ORCID-Profile: Rulong Shen

Zitieren

APA

Li, B. C., Hammond, S., Parwani, A. V., & Shen, R. (2024). Artificial intelligence algorithm accurately assesses oestrogen receptor immunohistochemistry in metastatic breast cancer cytology specimens: A pilot study. Cytopathology, 35(4), 464-472. https://doi.org/10.1111/cyt.13373

Vancouver

Li BC, Hammond S, Parwani AV, Shen R. Artificial intelligence algorithm accurately assesses oestrogen receptor immunohistochemistry in metastatic breast cancer cytology specimens: A pilot study. Cytopathology. 2024;35(4):464-472. doi:10.1111/cyt.13373

BibTeX
@article{Li2024,
  author = {Li, Brenna C and Hammond, Scott and Parwani, Anil V and Shen, Rulong},
  title = {Artificial intelligence algorithm accurately assesses oestrogen receptor immunohistochemistry in metastatic breast cancer cytology specimens: A pilot study},
  journal = {Cytopathology},
  year = {2024},
  volume = {35},
  number = {4},
  pages = {464--472},
  doi = {10.1111/cyt.13373}
}
Kostenlos starten →